Integrated target-based and phenotypic screening approaches for the identification of anti-tubercular agents that bind to the mycobacterial adenylating enzyme MbtA

Lindsay Ferguson, Geoff Wells, Sanjib Bhakta, James Johnson, Junitta Guzman, Tanya Parish, Robin A. Prentice, Federico Brucoli

Research output: Contribution to journalArticle

Abstract

Iron is essential for the pathogenicity and virulence of Mycobacterium tuberculosis, which synthesises salicyl‐capped siderophores (mycobactins) to acquire this element from the host. MbtA is the adenylating enzyme that catalyses the initial reaction of mycobactin biosynthesis and is solely expressed by mycobacteria. A 3200‐member library comprised of lead‐like, structurally diverse compounds was screened against M. tuberculosis for whole‐cell inhibitory activity. A set of 846 compounds that inhibited the tubercle bacilli growth were then tested for their ability to bind to MbtA using a fluorescence‐based thermal shift assay and NMR‐based Water‐LOGSY and saturation transfer difference (STD) experiments. We identified an attractive hit molecule, 5‐hydroxyindol‐3‐ethylamino‐(2‐nitro‐4‐trifluoromethyl)benzene (5), that bound with high affinity to MbtA and produced a MIC90 value of 13 μm. The ligand was docked into the MbtA crystal structure and displayed an excellent fit within the MbtA active pocket, adopting a binding mode different from that of the established MbtA inhibitor Sal‐AMS.
Original languageEnglish
Pages (from-to)1735-1741
Number of pages7
JournalChemMedChem
Volume14
Issue number19
Early online date27 Aug 2019
DOIs
Publication statusPublished - 4 Oct 2019

Keywords

  • Compound screening
  • Iron homeostasis
  • Mycobactins
  • NMR spectroscopy
  • Siderophores
  • Tuberculosis

Cite this

Ferguson, Lindsay ; Wells, Geoff ; Bhakta, Sanjib ; Johnson, James ; Guzman, Junitta ; Parish, Tanya ; Prentice, Robin A. ; Brucoli, Federico. / Integrated target-based and phenotypic screening approaches for the identification of anti-tubercular agents that bind to the mycobacterial adenylating enzyme MbtA. In: ChemMedChem. 2019 ; Vol. 14, No. 19. pp. 1735-1741.
@article{4667e7dfb3ad494daf67e723e5603ac5,
title = "Integrated target-based and phenotypic screening approaches for the identification of anti-tubercular agents that bind to the mycobacterial adenylating enzyme MbtA",
abstract = "Iron is essential for the pathogenicity and virulence of Mycobacterium tuberculosis, which synthesises salicyl‐capped siderophores (mycobactins) to acquire this element from the host. MbtA is the adenylating enzyme that catalyses the initial reaction of mycobactin biosynthesis and is solely expressed by mycobacteria. A 3200‐member library comprised of lead‐like, structurally diverse compounds was screened against M. tuberculosis for whole‐cell inhibitory activity. A set of 846 compounds that inhibited the tubercle bacilli growth were then tested for their ability to bind to MbtA using a fluorescence‐based thermal shift assay and NMR‐based Water‐LOGSY and saturation transfer difference (STD) experiments. We identified an attractive hit molecule, 5‐hydroxyindol‐3‐ethylamino‐(2‐nitro‐4‐trifluoromethyl)benzene (5), that bound with high affinity to MbtA and produced a MIC90 value of 13 μm. The ligand was docked into the MbtA crystal structure and displayed an excellent fit within the MbtA active pocket, adopting a binding mode different from that of the established MbtA inhibitor Sal‐AMS.",
keywords = "Compound screening, Iron homeostasis, Mycobactins, NMR spectroscopy, Siderophores, Tuberculosis",
author = "Lindsay Ferguson and Geoff Wells and Sanjib Bhakta and James Johnson and Junitta Guzman and Tanya Parish and Prentice, {Robin A.} and Federico Brucoli",
year = "2019",
month = "10",
day = "4",
doi = "10.1002/cmdc.201900217",
language = "English",
volume = "14",
pages = "1735--1741",
journal = "ChemMedChem",
issn = "1860-7179",
publisher = "Wiley",
number = "19",

}

Integrated target-based and phenotypic screening approaches for the identification of anti-tubercular agents that bind to the mycobacterial adenylating enzyme MbtA. / Ferguson, Lindsay; Wells, Geoff; Bhakta, Sanjib; Johnson, James; Guzman, Junitta; Parish, Tanya; Prentice, Robin A.; Brucoli, Federico.

In: ChemMedChem, Vol. 14, No. 19, 04.10.2019, p. 1735-1741.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Integrated target-based and phenotypic screening approaches for the identification of anti-tubercular agents that bind to the mycobacterial adenylating enzyme MbtA

AU - Ferguson, Lindsay

AU - Wells, Geoff

AU - Bhakta, Sanjib

AU - Johnson, James

AU - Guzman, Junitta

AU - Parish, Tanya

AU - Prentice, Robin A.

AU - Brucoli, Federico

PY - 2019/10/4

Y1 - 2019/10/4

N2 - Iron is essential for the pathogenicity and virulence of Mycobacterium tuberculosis, which synthesises salicyl‐capped siderophores (mycobactins) to acquire this element from the host. MbtA is the adenylating enzyme that catalyses the initial reaction of mycobactin biosynthesis and is solely expressed by mycobacteria. A 3200‐member library comprised of lead‐like, structurally diverse compounds was screened against M. tuberculosis for whole‐cell inhibitory activity. A set of 846 compounds that inhibited the tubercle bacilli growth were then tested for their ability to bind to MbtA using a fluorescence‐based thermal shift assay and NMR‐based Water‐LOGSY and saturation transfer difference (STD) experiments. We identified an attractive hit molecule, 5‐hydroxyindol‐3‐ethylamino‐(2‐nitro‐4‐trifluoromethyl)benzene (5), that bound with high affinity to MbtA and produced a MIC90 value of 13 μm. The ligand was docked into the MbtA crystal structure and displayed an excellent fit within the MbtA active pocket, adopting a binding mode different from that of the established MbtA inhibitor Sal‐AMS.

AB - Iron is essential for the pathogenicity and virulence of Mycobacterium tuberculosis, which synthesises salicyl‐capped siderophores (mycobactins) to acquire this element from the host. MbtA is the adenylating enzyme that catalyses the initial reaction of mycobactin biosynthesis and is solely expressed by mycobacteria. A 3200‐member library comprised of lead‐like, structurally diverse compounds was screened against M. tuberculosis for whole‐cell inhibitory activity. A set of 846 compounds that inhibited the tubercle bacilli growth were then tested for their ability to bind to MbtA using a fluorescence‐based thermal shift assay and NMR‐based Water‐LOGSY and saturation transfer difference (STD) experiments. We identified an attractive hit molecule, 5‐hydroxyindol‐3‐ethylamino‐(2‐nitro‐4‐trifluoromethyl)benzene (5), that bound with high affinity to MbtA and produced a MIC90 value of 13 μm. The ligand was docked into the MbtA crystal structure and displayed an excellent fit within the MbtA active pocket, adopting a binding mode different from that of the established MbtA inhibitor Sal‐AMS.

KW - Compound screening

KW - Iron homeostasis

KW - Mycobactins

KW - NMR spectroscopy

KW - Siderophores

KW - Tuberculosis

U2 - 10.1002/cmdc.201900217

DO - 10.1002/cmdc.201900217

M3 - Article

VL - 14

SP - 1735

EP - 1741

JO - ChemMedChem

JF - ChemMedChem

SN - 1860-7179

IS - 19

ER -